{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:26:55Z","timestamp":1786984015956,"version":"build-2736575974"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:p>This cross-sectional study investigates the cost and coverage of ustekinumab originator Stelara and biosimilar products in 2026 for Medicare Part D.<\/jats:p>","DOI":"10.1001\/jamanetworkopen.2026.31556","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:30:29Z","timestamp":1786980629000},"page":"e2631556","source":"Crossref","is-referenced-by-count":0,"title":["Cost and Coverage of Originator and Biosimilar Ustekinumab Products in Medicare Part D"],"prefix":"10.1001","volume":"9","author":[{"given":"Grace","family":"Castle","sequence":"first","affiliation":[{"name":"Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Carrier","sequence":"additional","affiliation":[{"name":"Rutgers University Law School, Camden, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Sachs","sequence":"additional","affiliation":[{"name":"Washington University in St Louis School of Law, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Keating","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiden A.","family":"Huskamp","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie B.","family":"Dusetzina","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"zld260177r7","doi-asserted-by":"publisher","DOI":"10.1002\/acr.80024","article-title":"Major US formulary change triggers, but does not sustain, increases in biosimilar adalimumab prescribing.","author":"Roberts","year":"2026","journal-title":"Arthritis Care Res"},{"key":"zld260177r1","unstructured":"Centers for Medicare and Medicaid Services. Medicare Drug Price Negotiation Program: negotiated prices for initial price applicability year 2026. August 2024. Accessed on April 20, 2026. https:\/\/www.cms.gov\/files\/document\/fact-sheet-negotiated-prices-initial-price-applicability-year-2026.pdf"},{"key":"zld260177r2","unstructured":"Fein? AJ. The top pharmacy benefit managers of 2024: market share and key industry developments. March 31, 2025. Drug Channels. Accessed November 22, 2025. https:\/\/www.drugchannels.net\/2025\/03\/the-top-pharmacy-benefit-managers-of.html"},{"key":"zld260177r3","unstructured":"Centers for Medicare and Medicaid Services. Monthly prescription drug plan formulary and pharmacy network information. October 2025. Accessed November 12, 2025. https:\/\/data.cms.gov\/provider-summary-by-type-of-service\/medicare-part-d-prescribers\/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information"},{"key":"zld260177r4","unstructured":"Centers for Medicare and Medicaid Services. Quarterly Prescription Drug Plan Formulary, Pharmacy Network, and Pricing Information. Accessed June 24, 2026. https:\/\/data.cms.gov\/provider-summary-by-type-of-service\/medicare-part-d-prescribers\/quarterly-prescription-drug-plan-formulary-pharmacy-network-and-pricing-information"},{"key":"zld260177r5","unstructured":"Campen? B. HCSC Completes the Acquisition of The Cigna Group\u2019s Medicare and CareAllies Businesses. March 19, 2025. Health Care Service Corporation. Accessed January 20, 2026. https:\/\/www.hcsc.com\/newsroom\/news-releases\/2025\/completes-cigna-medicare-acquisition"},{"key":"zld260177r6","unstructured":"Frier Levitt. Cigna announces $3.7 billion deal to sell Medicare business. February 22, 2024. Accessed January 20, 2026. https:\/\/www.frierlevitt.com\/articles\/cigna-announces-3-7-billion-deal-to-sell-medicare-business\/"},{"key":"zld260177r8","unstructured":"Aetna. Drug search: 2026 Aetna standard plan. Accessed January 20, 2026. https:\/\/client.formularynavigator.com\/Search.aspx?siteCode=3847216253"},{"key":"zld260177r9","unstructured":"Cigna Healthcare. Medication Coverage Changes for 2026. Accessed January 20, 2026. https:\/\/www.cigna.com\/static\/www-cigna-com\/docs\/2026-prescription-drug-list-changes.pdf"},{"key":"zld260177r10","unstructured":"UnitedHealthcare. 2026 Prescription drug list, effective January 1, 2026: UnitedHealthcare & affiliated companies. Accessed January 20, 2026. https:\/\/www.uhcprovider.com\/content\/dam\/provider\/docs\/public\/resources\/pharmacy\/commercial-pdl-jan-2026.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852899\/castle_2026_ld_260177_1786551148.01671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:30:30Z","timestamp":1786980630000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.31556","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}